Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Durk H.   Kneba M.   Dickgreber N.   Welte T.   Muller T.   Scholtze J.   Graeven U.   Jasiewicz Y.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 654-660

Elsevier

Access to resources Recommend Favorite

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

By Xu N.   Shen P.   Zhang X.   Yu L.   Bao H.   Shi G.   Huang S.   Chen J.   Mou H.   Fang W.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite

A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer

By            

Oncology Reports, Vol. 28, Iss. 3, 2012-01 ,pp. : 763-767

Spandidos Publications

Access to resources Recommend Favorite

Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial

By Krajnik G.   Wein W.   Greil R.   Marhold F.   Mohn-Staudner A.   Kummer F.   Malayeri R.   Zochbauer-Muller S.   Huber H.   Pirker R.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1977-1980

Elsevier

Access to resources Recommend Favorite